NextGen eCTD Software Supported by WHO: Advancing Global Regulatory Submissions with Masuu Global
The world pharmaceutical sector is changing fast and NextGen eCTD Software supported by WHO is emerging as a main force behind harmonized, efficient regulatory submissions. Countries are also implementing the modern electronic standards of submission with the guidance and support of the World Health Organization to enhance the quality, consistency, and speed of regulatory reviews. Masuu Global assists companies to smoothly switch to such progressive frameworks, which make them comply with international standards.
WHO’s Role in Regulatory Digital Transformation
The World Health Organization plays a critical role in promoting standardized WHO Prequalification Regulatory Practices Program from April 2026, for New Products across member countries. By encouraging the adoption of electronic submission formats, WHO supports improved data integrity, structured documentation, and better lifecycle management. These initiatives are particularly important for emerging markets aiming to align with global regulatory systems.
Benefits of WHO-Supported eCTD Implementation
Implementing eCTD frameworks supported by WHO has several benefits to pharmaceutical organizations. These are better organization of dossiers, better traceability of documents, and less error in submissions. Electronic formats also help in a quicker reply between the applicants and the regulatory bodies and lead to a more effective schedule of review. Also harmonized standards enable companies to control submissions in different regions.
How Masuu Global Enables Compliance
Masuu Global provides end-to-end support for organizations adopting WHO-aligned eCTD standards. Our services include dossier publishing, validation, and regulatory consulting tailored to global requirements. By leveraging advanced tool eCTD software and deep industry expertise, we ensure that submissions are accurate, compliant, and ready for review by health authorities worldwide.
Preparing for the Future of Global Submissions
As more countries embrace WHO-supported regulatory frameworks, companies must be proactive in adopting digital submission practices. Partnering with Masuu Global enables organizations to stay ahead of evolving requirements, reduce regulatory risks, and accelerate approvals. This strategic approach ensures long-term success in an increasingly competitive and regulated global pharmaceutical landscape.